The FDA has cleared Medtronic’s latest spinal cord stimulation system for the treatment of chronic intractable pain.

Designed to surmount limitations of current devices, the Intellis platform comprises an implantable neurostimulator that records patient activity around the clock, a patient programmer, and a recharger. A physician manages the treatment on a tablet that allows the wireless programming of stimulation.